Preenapun Saokhieo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Preenapun Saokhieo has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Pojsakorn Danpanichkul
Department of Internal Medicine Texas Tech University Health Sciences Center Lubbock Texas USA
2 shared publications - Yanfang Pang
Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
2 shared publications - Ahmad Anouti
Department of Pediatrics University of Texas Southwestern Medical Center Dallas Texas USA
1 shared publication Allan Bueso
Department of Internal Medicine Texas Tech University Health Sciences Center Lubbock Texas USA
1 shared publication- Amit G. Singal
Department of Internal Medicine University of Texas Southwestern Medical Center Dallas Texas USA
1 shared publication - Apichat Kaewdech
Prince of Songkla University
1 shared publication
Latest Publications
- 15 September 2026
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 50 (9)
Association of a Reported Penicillin Allergy Label With Clinical Outcomes in Alcohol‐Associated Liver Disease
Background: Penicillin allergy is commonly reported but often unconfirmed, leading to avoidance of first‐line antibiotics. Patients with alcohol‐associated liver disease (ALD) are particularly vulnerable to infections and hepatic complications; however, the impact of a documented penicillin allergy label on clinical outcomes in this population remains unclear. Methods: We conducted a retrospective cohort study using the TriNetX research network. Adults with ALD were classified by the presence or absence of a documented penicillin allergy label. After 1:1 propensity score matching on demographics, comorbidities, laboratory parameters, and treatments, 2388 patients were included, with 1194 in each cohort. Patients were followed for up to 5 years. Cox proportional hazards models estimated hazard ratios (HRs) and 95% confidence intervals (CIs). Results: A documented penicillin allergy label was associated with higher risks of sepsis (11.4% vs. 6.4%; HR, 1.53; 95% CI, 1.16–2.02), pneumonia (8.7% vs. 5.0%; HR, 1.49; 95% CI, 1.09–2.05), urinary tract infection (11.7% vs. 6.6%; HR, 1.55; 95% CI, 1.17–2.04), influenza pneumonia (10.7% vs. 6.1%; HR, 1.51; 95% CI, 1.12–2.04), and alcohol‐associated hepatitis (19.0% vs. 13.5%; HR, 1.27; 95% CI, 1.04–1.55). The association with major adverse liver outcomes was not significant (9.5% vs. 6.9%; HR, 1.18; 95% CI, 0.89–1.57). Conclusions: In patients with ALD, a documented penicillin allergy label was associated with several infection‐related outcomes and alcohol‐associated hepatitis, but not with major adverse liver outcomes. Formal penicillin allergy evaluation may help optimize antibiotic selection in this high‐risk population.
- 15 September 2026
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 50 (9)
Association of a Reported Penicillin Allergy Label With Clinical Outcomes in Alcohol‐Associated Liver Disease
Background: Penicillin allergy is commonly reported but often unconfirmed, leading to avoidance of first‐line antibiotics. Patients with alcohol‐associated liver disease (ALD) are particularly vulnerable to infections and hepatic complications; however, the impact of a documented penicillin allergy label on clinical outcomes in this population remains unclear. Methods: We conducted a retrospective cohort study using the TriNetX research network. Adults with ALD were classified by the presence or absence of a documented penicillin allergy label. After 1:1 propensity score matching on demographics, comorbidities, laboratory parameters, and treatments, 2388 patients were included, with 1194 in each cohort. Patients were followed for up to 5 years. Cox proportional hazards models estimated hazard ratios (HRs) and 95% confidence intervals (CIs). Results: A documented penicillin allergy label was associated with higher risks of sepsis (11.4% vs. 6.4%; HR, 1.53; 95% CI, 1.16–2.02), pneumonia (8.7% vs. 5.0%; HR, 1.49; 95% CI, 1.09–2.05), urinary tract infection (11.7% vs. 6.6%; HR, 1.55; 95% CI, 1.17–2.04), influenza pneumonia (10.7% vs. 6.1%; HR, 1.51; 95% CI, 1.12–2.04), and alcohol‐associated hepatitis (19.0% vs. 13.5%; HR, 1.27; 95% CI, 1.04–1.55). The association with major adverse liver outcomes was not significant (9.5% vs. 6.9%; HR, 1.18; 95% CI, 0.89–1.57). Conclusions: In patients with ALD, a documented penicillin allergy label was associated with several infection‐related outcomes and alcohol‐associated hepatitis, but not with major adverse liver outcomes. Formal penicillin allergy evaluation may help optimize antibiotic selection in this high‐risk population.
- Open Access
- 15 July 2026
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 10 (8)
Contemporary global epidemiology of cirrhosis
Cirrhosis remains a major global cause of morbidity and mortality, with rapidly evolving etiologic drivers. This review summarizes the contemporary global epidemiology of cirrhosis, highlighting regional patterns and major transitions in underlying causes to inform prevention and policy. In 2021, cirrhosis and chronic liver disease accounted for ~1.4 million deaths worldwide. Although age-standardized mortality rates have declined in many regions, the absolute burden continues to rise due to population growth and aging. Reductions in hepatitis B and C–related cirrhosis, driven by vaccination, screening, and antiviral therapy, have been offset by a growing contribution from steatotic liver disease. High–sociodemographic index (SDI) regions exhibit lower mortality but increasing prevalence, reflecting improved survival and expanding metabolic risk, whereas low- and lower-middle–SDI regions continue to experience high mortality. Addressing the global burden of cirrhosis will require sustained public health investment focused on viral hepatitis elimination, alcohol-associated harm reduction, metabolic risk management, and equitable access to early detection and care.
- 15 July 2026
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 10 (8)
Open AccessContemporary global epidemiology of cirrhosis
Cirrhosis remains a major global cause of morbidity and mortality, with rapidly evolving etiologic drivers. This review summarizes the contemporary global epidemiology of cirrhosis, highlighting regional patterns and major transitions in underlying causes to inform prevention and policy. In 2021, cirrhosis and chronic liver disease accounted for ~1.4 million deaths worldwide. Although age-standardized mortality rates have declined in many regions, the absolute burden continues to rise due to population growth and aging. Reductions in hepatitis B and C–related cirrhosis, driven by vaccination, screening, and antiviral therapy, have been offset by a growing contribution from steatotic liver disease. High–sociodemographic index (SDI) regions exhibit lower mortality but increasing prevalence, reflecting improved survival and expanding metabolic risk, whereas low- and lower-middle–SDI regions continue to experience high mortality. Addressing the global burden of cirrhosis will require sustained public health investment focused on viral hepatitis elimination, alcohol-associated harm reduction, metabolic risk management, and equitable access to early detection and care.
- Open Access
- 1 July 2025
- Published by SAGE Publications in Journal of Primary Care & Community Health
- Vol. 16
Factors Associated with Falls in Older Adults: A Retrospective Hospital-Based Study Using Comprehensive Geriatric Assessment in Thailand (2020–2023)
Background: Falls are a leading cause of injury and disability in older adults, significantly impacting their quality of life. Identifying fall-related factors through comprehensive geriatric assessment (CGA) offers valuable insights into fall prevention strategies. This study aimed to explore factors associated with falls from CGA among older adults in Thailand. Methods: A retrospective cross-sectional study was conducted among older adults aged 60 years and older attending a geriatric clinic, Thailand between October 2020 and October 2023. Data were collected from electronic medical records, including personal information and CGA data (physical, psychological, and functional). The fall assessment was conducted on the same day by simply asking, “Have you ever fallen in the past year?”. The answer yes indicates a faller. Univariable and multivariable logistic regression analyses were performed to identify factors associated with falls. Results: Out of the 338 older adults, 96 (28.4%) reported a history of falls, 223 (65.98%) were older females, with a mean age of 69.76 ± 6.70 years. Significant factors of falls included advancing age (mOR 2.49, 95% CI 1.08-5.76, P -value = .033), female (mOR 1.92, 95% CI 1.02-3.61, P -value = .043), body mass index (BMI; mOR 0.92, 95% CI 0.85-0.99, P -value = .031), knee osteoarthritis (mOR 1.76, 95% CI 1.01-3.08, P -value = .045), and positive 2Q (mOR 0.33, 95% CI 0.11-0.99, P -value = .048). Conclusion: This study identified several CGA-derived factors—such as advanced age, female sex, lower BMI, knee osteoarthritis, and depression— that were associated with falls in older adults. These findings highlight the importance of integrating CGA into routine geriatric care to identify high-risk individuals and to inform targeted fall-prevention strategies in hospital settings.
- 1 July 2025
- Published by SAGE Publications in Journal of Primary Care & Community Health
- Vol. 16
Open AccessFactors Associated with Falls in Older Adults: A Retrospective Hospital-Based Study Using Comprehensive Geriatric Assessment in Thailand (2020–2023)
Background: Falls are a leading cause of injury and disability in older adults, significantly impacting their quality of life. Identifying fall-related factors through comprehensive geriatric assessment (CGA) offers valuable insights into fall prevention strategies. This study aimed to explore factors associated with falls from CGA among older adults in Thailand. Methods: A retrospective cross-sectional study was conducted among older adults aged 60 years and older attending a geriatric clinic, Thailand between October 2020 and October 2023. Data were collected from electronic medical records, including personal information and CGA data (physical, psychological, and functional). The fall assessment was conducted on the same day by simply asking, “Have you ever fallen in the past year?”. The answer yes indicates a faller. Univariable and multivariable logistic regression analyses were performed to identify factors associated with falls. Results: Out of the 338 older adults, 96 (28.4%) reported a history of falls, 223 (65.98%) were older females, with a mean age of 69.76 ± 6.70 years. Significant factors of falls included advancing age (mOR 2.49, 95% CI 1.08-5.76, P -value = .033), female (mOR 1.92, 95% CI 1.02-3.61, P -value = .043), body mass index (BMI; mOR 0.92, 95% CI 0.85-0.99, P -value = .031), knee osteoarthritis (mOR 1.76, 95% CI 1.01-3.08, P -value = .045), and positive 2Q (mOR 0.33, 95% CI 0.11-0.99, P -value = .048). Conclusion: This study identified several CGA-derived factors—such as advanced age, female sex, lower BMI, knee osteoarthritis, and depression— that were associated with falls in older adults. These findings highlight the importance of integrating CGA into routine geriatric care to identify high-risk individuals and to inform targeted fall-prevention strategies in hospital settings.